Clinical Trial

Implementing REmote SymPtom mOnitoring and maNagement (RESPONd)

Study acronym: RESPONd
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to understand if the implementation of a remote symptom monitoring and management program improves outcomes. The program will provide patients the opportunity to complete electronic Patient Reported Outcomes (PROs) questionnaires from home between appointments and receive tailored advice from a study nurse. A second goal of this study is to examine the impact of electronic symptom monitoring on clinic efficiencies. The main question it aims to answer is: • What impact does implementing digitally enabled remote symptom monitoring and management (RESPONd) between ambulatory oncology visits have on patient outcomes and system efficiencies? Participants will: * Report their symptoms and concerns from home by completing the electronic symptom monitoring questionnaire. * Discuss their symptoms and concerns with a study nurse. * Provide feedback about their experience at important timepoints during the study. * Participate as usual in ambulatory clinic appointments.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-12.
Trial Details
NCT Number NCT07024329
Lead Sponsor University of Calgary
Collaborators: Alberta Health services, Alberta Innovates Health Solutions
Conditions Cancer
Enrollment 1,055 participants
Start Date 2025-05-16
Primary Completion 2026-11-30 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-30